Product Details
Act Buprenorphine/Naloxone
Buprenorphine + Naloxone8 mg + 2 mg
Sublingual Tablet
DIN/PIN/NPN
02453916
Manufacturer
Actavis Pharma Company
Formulary Listing Date
2018-01-31
Unit Price
1.1825
Amount MOH Pays
1.1825
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
N07BC51
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02295709 | Suboxone | 4.8293 | 1.1825 |
| 02424878 | PMS-Buprenorphine-Naloxone | 1.1825 | 1.1825 |
| 02453916 | Act Buprenorphine/Naloxone | 1.1825 | 1.1825 |
| 02517183 | Taro-Buprenorphine / Naloxone | 1.1825 | 1.1825 |
LU Clinical Criteria
NORequirements